Founded in 2001 by Phillip Gross and Robert George Atchinson, Adage Capital Management has $8.9 billion under its management and has consistently outperformed the S&P index for the past 15 years. The firm invests in early-stage and late-stage ventures, with notable investments including MedAvail, Annexon Biosciences, Cabaletta Bio, GitLab, Precision BioSciences, Prevail Therapeutics, Scout Bio, and Tanium. They have made 41 investments and had 28 exits as of January 2020. Adage Capital Management primarily serves endowments and foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross, and the Getty Foundation.